·
COMMENTARY
·
Atom-engineered metabzymes for catalytic metabolic regulation-augmented immunotherapy
Show Less
1
Department of Ultrasound, Second Affiliated Hospital of Chongqing Medical University, Chongqing,
P. R. China
2
Chongqing Key Laboratory of Ultrasound Molecular Imaging, Second Affiliated Hospital of Chongqing Medical University, Chongqing,
P. R. China
BMT 2025 , 6(1), 110–111;
https://doi.org/10.12336/biomatertransl.2025.01.010
Submitted: 9 February 2025 | Revised: 12 March 2025 | Accepted: 13 March 2025 | Published: 25 March 2025
Copyright © 2025 by the Author(s). This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution–NonCommercial–ShareAlike 4.0 License.
Funding
This work was financially supported by the National Natural Science Foundation of China (Grant Nos. 82472011, 82171946), the CQMU Program for Youth Innovation in Future Medicine (W0026), the Joint Project of Pinnacle Disciplinary Group at the Second Affiliated Hospital of Chongqing Medical (2024205), and the Kuanren Talents Program of the Second Affiliated Hospital of Chongqing Medical University (KR2024G006).
References
Below is the content of the Citations in the paper which has been de-formatted, however, the content stays consistent with the original.
- Del Paggio JC. Cancer immunotherapy and the value of cure. Nat Rev Clin Oncol. 2018;15:268-270. doi: 10.1038/nrclinonc.2018.27
- Huang AC, Zappasodi R. A decade of checkpoint blockade immunotherapy in melanoma: Understanding the molecular basis for immune sensitivity and resistance. Nat Immunol. 2022;23:660-670. doi: 10.1038/s41590-022-01141-1
- Faubert B, Solmonson A, DeBerardinis RJ. Metabolic reprogramming and cancer progression. Science. 2020;368:eaaw5473. doi: 10.1126/science.aaw5473
- Stine ZE, Schug ZT, Salvino JM, Dang CV. Targeting cancer metabolism in the era of precision oncology. Nat Rev Drug Discov. 2022;21:141-162. doi: 10.1038/s41573-021-00339-6
- Goga A, Stoffel M. Therapeutic RNA-silencing oligonucleotides in metabolic diseases. Nat Rev Drug Discov. 2022;21:417-439. doi: 10.1038/s41573-022-00407-5
- Ji S, Jiang B, Hao H, et al. Matching the kinetics of natural enzymes with a single-atom iron nanozyme. Nat Catal. 2021;4:407-417. doi: 10.1038/s41929-021-00609-x
- Zhang R, Jiang B, Fan K, Gao L, Yan X. Designing nanozymes for in vivo applications. Nat Biomed Eng. 2024;2:849-868. doi: 10.1038/s44222-024-00205-1
- Hu X, Zhang B, Zhang M, et al. An artificial metabzyme for tumour-cell-specific metabolic therapy. Nat Nanotechnol. 2024;19:1712-1722. doi: 10.1038/s41565-024-01733-y
Conflict of interest
The authors declare no competing interest.
